Imperagen

About
What does Imperagen do?
Imperagen is a biotechnology company focused on developing innovative drug delivery systems. Their technology aims to improve the efficacy and patient experience of various therapeutic treatments. (formerly [].)
What is Imperagen's revenue?
StartupHub estimates Imperagen's annual revenue at $1.0M (range $350K to $3.0M, 34% confidence), based on comparable companies in the sector.
What is Imperagen's valuation?
StartupHub estimates Imperagen's effective valuation at $25.9M (range $16.8M to $40.2M, 24% confidence), based on comparable companies in the sector.
How much funding has Imperagen raised?
Imperagen has raised a total of $7M in funding. The most recent round on record is Seed.
Where is Imperagen headquartered?
Imperagen is headquartered in Cambridge, England, United Kingdom.
When was Imperagen founded?
Imperagen was founded in 2017.
What industry does Imperagen operate in?
Imperagen operates in Biotechnology, Pharmaceuticals, Drug Delivery, Biotech, MedTech, Drug Discovery.
No comments yet. Be the first to share your take.
